IMPLICATIONS FOR PATIENT CARE: [18F]CTT1057 can be added to the armamentarium of PSMA-targeted PET tracers, thus increasing patient access to proper diagnosis and tailored PCa treatment. The gene discussed is FOLH1; the disease is posterior cortical atrophy.